PPI Interface-Targeting Ligand Design Services
* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Many of the most valuable targets in a degradation pipeline have no classical binding pocket at all. Their disease relevance comes from the company they keep: transcription factors reading coactivator grooves, kinases docking substrate motifs, scaffolds assembling signaling complexes. For these proteins, a warhead has to work where biology happens, which is at the protein-protein interaction (PPI) interface rather than inside an enzymatic cavity.
BOC Sciences provides PPI interface-targeting warhead design services for PROTAC development, covering interface mapping, hotspot identification, small-molecule ligand discovery, binding-mode characterization, and structure-guided optimization. We integrate computational modeling, compound screening, biophysical characterization, and medicinal chemistry strategies to identify ligands that recognize target protein interaction surfaces.
Request a Consultation Explore ServicesWhat Is a PPI Interface-Targeting Warhead in Targeted Protein Degradation?
A PPI interface-targeting warhead is a target-binding ligand—small molecule, peptide, peptidomimetic, or covalent chemotype—designed to recognize the energetic hot spots of the surface a protein uses to bind its partner proteins. Instead of occupying a deep orthosteric pocket, it anchors to the grooves, shallow depressions, and hot regions that define an interface, and it can either disrupt the native interaction or stabilize a specific interface state. Because hot spots are usually the least conserved part of a protein surface, warheads built on them often achieve selectivity among close homologs that pocket-directed ligands cannot reach, and they extend degrader design to proteins whose only ligandable feature is the interface itself.
BOC Sciences PPI Interface-Targeting Warhead Design Services for PROTAC Development
BOC Sciences provides integrated PPI interface-targeting warhead design services, from identifying suitable protein interaction regions to discovering and optimizing target-binding ligands. Our approach combines protein structure analysis, computational screening, experimental binding evaluation, and medicinal chemistry to develop warheads suitable for PROTAC construction.
-
PPI Interface Mapping and Hotspot Identification
Identifying suitable binding regions is the foundation of PPI-targeting warhead design. BOC Sciences analyzes target protein structures and protein complexes to identify key interaction residues, binding hotspots, and potential ligand-binding regions. We evaluate interface geometry, residue contributions, hydrophobic interactions, and local pocket characteristics to determine whether an interaction surface offers opportunities for ligand discovery. When experimental structures are unavailable, in silico protein-protein interaction prediction and structural modeling can help investigate potential interface regions and guide subsequent warhead design.
-
Small-Molecule PPI Warhead Discovery and Screening
For interfaces with suitable binding hotspots or subpockets, BOC Sciences supports small-molecule warhead discovery through structure-based virtual screening, fragment-based approaches, and compound screening. Candidate molecules are selected according to their potential interactions with key interface residues, structural complementarity, and chemical properties. Our screening strategies aim to identify promising starting compounds that can be further optimized into target-binding warheads for PROTAC development. Virtual screening can be integrated with experimental hit evaluation to support candidate selection.
-
Binding-Mode Characterization and Interface Engagement Validation
Identifying how a candidate ligand binds to the target protein is essential for confirming its suitability as a PPI-targeting warhead. BOC Sciences combines computational analysis and experimental binding studies to investigate ligand orientation, key residue interactions, and engagement with the intended interface. Depending on the target and available materials, binding affinity measurements and PPI competition assays can help distinguish direct target binding from functional changes in protein interactions. These results provide a basis for selecting and optimizing promising warhead candidates.
-
Warhead Optimization and Linker-Attachment Site Selection
A suitable PPI-targeting warhead must retain target recognition after linker attachment. BOC Sciences optimizes candidate scaffolds through structural analysis and SAR studies, focusing on improving binding interactions while identifying suitable linker exit vectors. We also evaluate how chemical modifications and linker attachment may affect warhead orientation, molecular properties, and target accessibility. These considerations help prepare optimized ligands for integration into PROTAC structures. Our linker design and optimization services can further support the selection of suitable linker configurations.
PPI Interface Classes We Target for Warhead Design
Different protein interactions involve distinct recognition surfaces and structural features. BOC Sciences evaluates the biological function and structural characteristics of each PPI to identify suitable interface regions for warhead development.
-
Transcription Factor-Coactivator and Corepressor Interfaces
Transcription factors interact with coactivators and corepressors to regulate gene expression and assemble transcriptional complexes. These interactions often involve specific binding grooves, hydrophobic recognition regions, or short protein motifs. BOC Sciences analyzes these interfaces to identify key recognition residues and potential ligand-binding sites, supporting the discovery of warheads for transcriptional regulators that may lack conventional small-molecule-binding pockets.
-
Protein Dimerization and Oligomerization Interfaces
Many proteins require dimerization or oligomerization to maintain their structural organization or biological functions. These interfaces may contain hydrophobic contact regions, complementary binding surfaces, and specific residue hotspots. BOC Sciences investigates the interaction regions responsible for protein assembly and evaluates their potential for ligand recognition, with particular attention to interface accessibility and differences between homo- and heteromeric complexes.
-
Enzyme-Regulatory Protein and Substrate-Recognition Interfaces
Enzymes often interact with regulatory proteins or protein substrates through recognition regions outside their catalytic sites. These interfaces may control substrate recruitment, enzyme regulation, and protein complex formation. BOC Sciences analyzes these non-catalytic interaction surfaces to identify important binding residues and potential warhead-binding regions, providing alternative ligand discovery opportunities for enzymes with challenging conventional binding pockets.
-
Scaffold-Mediated Multiprotein Assembly Interfaces
Scaffold proteins organize multiple interacting partners into functional protein complexes through distinct binding domains and recognition motifs. Their interaction surfaces can provide opportunities for developing warheads against proteins involved in complex assembly and cellular signaling. BOC Sciences evaluates individual scaffold-partner interfaces, identifies potential ligand-binding regions, and considers interaction selectivity to prioritize suitable target-binding sites for PROTAC development.
Which Interface Class Does Your Target Belong To?
Share your target protein, its interaction partners, and any available structural information with BOC Sciences. Our experts will classify the relevant interfaces, evaluate their hot-spot architecture and ligandability, and propose the warhead strategy most likely to support productive degradation.
Warhead Modalities for Engaging PPI Interfaces
The selection of a suitable warhead depends on the size, shape, and chemical characteristics of the target PPI interface. BOC Sciences considers different ligand modalities to address diverse interaction surfaces, from localized binding hotspots to extended protein recognition regions.
-
Small-Molecule Hot-Spot Warheads
Small-molecule warheads are suitable for PPI interfaces containing localized hotspots, hydrophobic pockets, or recognizable binding grooves. Their design focuses on identifying key interaction residues and developing chemical scaffolds that complement these regions. BOC Sciences supports fragment screening, virtual screening, and structure-guided optimization to identify small molecules with suitable target-binding properties. Particular attention is given to binding affinity, ligand efficiency, and the availability of an appropriate linker attachment position for PROTAC construction. Our small-molecule target protein ligand design capabilities can support this process.
-
Peptide and Epitope-Mimetic Warheads
Peptide and epitope-mimetic warheads reproduce important recognition features of natural protein interaction partners. They are particularly relevant to interfaces involving short peptide motifs or defined structural elements, such as alpha-helical binding regions. BOC Sciences evaluates interface-derived sequences and key amino acid interactions to design peptides or molecular mimics capable of recognizing the target protein. Sequence modification and chemical optimization can further improve binding properties and provide suitable positions for linker attachment. Our peptide ligand design capabilities can support these projects.
-
Macrocyclic and Conformationally Constrained Peptide Warheads
Macrocyclic and conformationally constrained peptides are designed to maintain a more defined three-dimensional structure for target recognition. By restricting peptide flexibility, these approaches can help preserve the spatial arrangement of important binding residues and reduce some limitations associated with linear peptides. BOC Sciences considers cyclization strategies, amino acid modifications, and conformational optimization to develop peptide warheads with suitable binding properties and linker compatibility.
-
Covalent Interface Warheads
Covalent interface warheads combine a target-recognition scaffold with a reactive group designed to engage a suitably positioned amino acid residue on or near the PPI interface. This approach may provide an alternative binding strategy when the target interface contains an accessible reactive residue, such as an appropriate cysteine. BOC Sciences considers residue accessibility, local chemical environment, binding orientation, and covalent reactivity during design to support selective target engagement. Linker attachment must also preserve the recognition geometry and avoid interfering with the intended covalent interaction.
Need a Warhead Format Matched to Your Interface?
Small molecule, epitope-mimetic peptide, constrained macrocycle, or covalent chemotype—each solves a different interface problem. Tell BOC Sciences about your target and its structural data, and our team will recommend the modality with the highest probability of becoming a productive degrader warhead.
Our PPI Interface-Targeting Warhead Design Workflow
Project Consultation and Interface Feasibility Assessment
We review the target, its interaction partners, available complex structures, and the degradation question you are pursuing. The output is a written assessment of which interfaces on the target are worth pursuing and whether an interface-targeting route is justified for your program.
Hot-Spot Mapping and Interface Prioritization
Candidate interfaces are analyzed by structural comparison, energetic decomposition, and conformational sampling. Each interface is scored for hot-spot density, anchor-pocket quality, conservation, and exit-vector options, then ranked against the alternatives.
Warhead Discovery and Binding Validation
Discovery runs on the modality the interface supports, and every hit is confirmed in vitro with its binding site, interaction pattern, and interface-state effect documented before optimization. Weak binders with correct geometry are treated as assets; strong binders with the wrong geometry are not.
Structure-Guided Optimization and PROTAC Handoff
Optimized warheads are delivered with attachment-site options and a ternary complex assessment, then move directly into PROTAC design services for linker assembly and E3 ligand pairing.
Design Challenges We Solve in PPI Interface Warhead Programs
Interface-targeting warhead development brings difficulties that conventional ligand projects rarely meet. A candidate may bind measurably yet sit at the wrong part of the surface, affinity may stall at fragment scale, or engagement may never translate into a productive ternary complex. BOC Sciences works through these failure modes with you rather than around them.
Flat, Featureless Interfaces with No Obvious Druggable Pocket
Many interfaces present thousands of square angstroms of shallow surface with no visible cavity, which makes conventional docking unproductive and discourages chemistry. The pocket that matters, however, often exists only in a transient conformation or only in the bound state of the complex.
We address this by deconstructing the interface into hot regions and probing them with fragment-scale chemotypes, supported by molecular dynamics simulation to reveal cavities and grooves that appear across conformational ensembles. Once an anchor point is found, the warhead is grown outward across the surface instead of searching for depth that is not there.
Weak Fragment Affinity and Poor Ligand Efficiency
Fragments that bind individual hot spots typically show millimolar affinity, and naive growth often adds contacts without adding coherent energy. Programs stall here because each optimization cycle is judged on affinity alone rather than on how the contact network is being assembled.
Our optimization strategy builds the contact network deliberately: anchor-pocket binding is fixed first, adjacent hot spots are engaged in a defined order, and every analog is compared on ligand efficiency and pose retention rather than raw potency. This converts scattered weak contacts into a cooperative set that supports further degrader design.
Peptide Warhead Permeability and Proteolytic Stability
Epitope-mimetic peptides engage interfaces beautifully in biochemical assays and then fail in cells, because their size, charge, and exposed backbone make them poor membranes crossers and easy protease substrates. The problem compounds once a linker and an E3 ligand are attached.
We treat permeability and stability as design variables from the first analog series, not as late-stage fixes. Conformational constraint, backbone modification, terminal capping, and property-matched linker selection are evaluated together, so the warhead that reaches optimization is the one that can still engage its interface inside the cell.
Interface Engagement That Fails to Support a Productive Ternary Complex
Strong binding at an interface does not guarantee degradation. If the warhead's exit vector points into the target surface, or the E3 ligase can only be positioned on a face that clashes with the native partner, the resulting conjugate will form unproductive ternary complexes regardless of its binary affinity.
BOC Sciences evaluates every optimized warhead in the geometry of the complete degrader: exit-vector direction relative to the hot region, surface accessibility around the attachment point, and the orientation of the E3 ligase recruitment surface. When the geometry cannot be rescued by the linker, we say so early and propose an alternative interface on the same target.
Facing a Difficult PPI Interface in Your Degrader Program?
From flat surfaces and weak fragments to peptide permeability and ternary complex geometry, BOC Sciences can help diagnose why an interface warhead is underperforming and redirect the design. Describe your target and current results, and let our experts map the fastest route forward.
Why Choose BOC Sciences for PPI Interface-Targeting Warhead Design?
Integrated Computational and Experimental PPI Evaluation
Interface mapping, hot-spot prediction, docking, dynamics, and binding experiments run inside one team, so a predicted hot region and its experimental confirmation are never separated by a handoff.
Small-Molecule and Peptide-Based Warhead Design Options
Few providers design across both chemotype families. Offering small-molecule and peptide formats in parallel means the modality is chosen by the interface, not by the platform we happen to have.
Structure-Guided Optimization with PROTAC Compatibility in Mind
Every optimization cycle tracks exit-vector quality and ternary complex geometry alongside affinity, so the warhead you receive is ready for conjugation rather than merely potent in a binding assay.
Connected Support from Ligand Discovery to Degradation Assessment
Designed warheads can be carried straight into conjugate synthesis and evaluated by degradation ability assay from the same compound batch, closing the loop between design intent and degradation outcome.
Frequently Asked Questions (FAQ)
Not every protein-protein interaction (PPI) interface is suitable for small-molecule warhead development. Interfaces containing identifiable binding hotspots, localized hydrophobic pockets, shallow grooves, or clusters of important interaction residues generally offer better opportunities for ligand discovery. Although some PPI surfaces appear relatively flat, a limited number of key amino acid residues may contribute substantially to the overall binding energy. In addition, protein conformational changes may expose transient or cryptic binding pockets. BOC Sciences evaluates protein complex structures, interface hotspots, and local binding environments to help determine whether a target PPI interface offers suitable opportunities for warhead discovery and subsequent PROTAC development.
PPI hotspots are key amino acid residues that contribute substantially to the binding energy between interacting proteins. Their identification requires a combination of protein complex structural analysis, residue interaction assessment, and computational prediction rather than relying solely on the overall interface area. Common approaches include protein structure analysis, molecular docking, binding energy decomposition, alanine-scanning data analysis, and molecular dynamics simulations. Predicted hotspots should also be evaluated through ligand screening and experimental binding studies to determine whether they can support meaningful molecular recognition. BOC Sciences integrates computational analysis and experimental evaluation to identify interface regions that may serve as suitable starting points for small-molecule warhead discovery.
No. The primary function of a PPI-targeting warhead is to recognize and bind the target protein, rather than necessarily blocking its native interaction with another protein. Depending on its binding location and mechanism, a ligand may competitively interfere with the original PPI or engage a different region without directly disrupting the interaction. In PROTAC development, the more important requirement is that the warhead maintains target engagement and enables the complete degrader to form a productive ternary complex between the target protein and an E3 ligase. Therefore, PPI inhibition alone is not sufficient to determine whether a warhead is suitable for PROTAC development.
The appropriate warhead modality depends on the structural characteristics and molecular recognition mechanism of the target PPI interface. Small-molecule ligands are potential options for interfaces containing defined hotspots or localized binding pockets. Peptide and epitope-mimetic warheads may be suitable for interfaces that recognize specific alpha-helices, beta-strands, or short peptide motifs. Macrocyclic and conformationally constrained peptides can be considered when maintaining a defined three-dimensional structure is important for binding. Covalent warheads may also be explored when appropriately positioned and accessible reactive amino acid residues are present. The final selection should consider target engagement, molecular properties, and linker attachment compatibility.
BOC Sciences provides integrated services covering PPI interface analysis, warhead discovery, and structural optimization. We begin by analyzing the target protein and its interaction partners to identify important binding hotspots and potential ligand-binding regions. Based on interface characteristics, suitable small-molecule screening or other ligand discovery approaches are then applied, followed by experimental binding evaluation and structural characterization of candidate ligands. Promising candidates undergo further optimization of their chemical structures, binding properties, and linker attachment positions. We also consider ligand orientation within the complete PROTAC architecture and the requirements for productive ternary complex formation, helping clients identify suitable warhead candidates for subsequent targeted protein degradation research.
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Please contact us with any specific requirements and we will get back to you as soon as possible.